Mario Esteban Contreras Gamboa

Title: The Innovative Contributions of Mario Esteban Contreras Gamboa

Introduction

Mario Esteban Contreras Gamboa is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of gene transcription modulation. His work focuses on utilizing antisense oligonucleotides to target regulatory RNAs, which has implications for treating diseases linked to abnormal gene expression.

Latest Patents

Mario holds a patent for the modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs. This patent describes methods for modulating gene transcription, particularly through the use of antisense oligonucleotides (ASOs) that target promoter-associated RNAs and enhancer RNAs. These innovative methods are beneficial for increasing the expression of Carbamoyl-Phosphatase Synthetase 1 (CPS1), which can aid in treating diseases associated with aberrant gene expression. He has 1 patent to his name.

Career Highlights

Mario is currently associated with Camp4 Therapeutics Corporation, where he continues to advance his research and innovations. His work at the company emphasizes the importance of gene regulation and its potential therapeutic applications.

Collaborations

Some of his notable coworkers include Alfica Sehgal and Bryan J Matthews, who contribute to the collaborative environment at Camp4 Therapeutics Corporation.

Conclusion

Mario Esteban Contreras Gamboa's innovative work in gene transcription modulation showcases the potential of antisense oligonucleotides in therapeutic applications. His contributions are paving the way for advancements in treating diseases linked to gene expression.